blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1404874

EP1404874 - SCREENING METHOD [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.04.2008
Database last updated on 24.07.2024
Most recent event   Tooltip04.04.2008Application deemed to be withdrawnpublished on 07.05.2008  [2008/19]
Applicant(s)For all designated states
IVONEX, Gesellschaft für biomedizinische Forschung und Entwicklung mbH
Arnold-Heller-Strasse 7
24105 Kiel / DE
[2004/44]
Former [2004/15]For all designated states
Neumaier, Michael
Kappesgärten 20
68535 Edingen-Neckarhausen / DE
Inventor(s)01 / Neumaier, Michael
Kappesgärten 20
68535 Edingen-Neckarhausen / DE
 [2004/44]
Former [2004/15]01 / see applicant
...
Representative(s)Kröncke, Rolf, et al
Gramm, Lins & Partner
Patent- und Rechtsanwälte PartGmbB
Freundallee 13 a
30173 Hannover / DE
[N/P]
Former [2004/15]Kröncke, Rolf, Dr., et al
Gramm, Lins & Partner GbR Freundallee 13
30173 Hannover / DE
Application number, filing date02745418.028.06.2002
[2004/15]
WO2002EP07185
Priority number, dateDE200113138228.06.2001         Original published format: DE 10131382
[2004/15]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO03002764
Date:09.01.2003
Language:DE
[2003/02]
Type: A2 Application without search report 
No.:EP1404874
Date:07.04.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 09.01.2003 takes the place of the publication of the European patent application.
[2004/15]
Search report(s)International search report - published on:EP05.06.2003
ClassificationIPC:C12Q1/68, G01N33/50, A61P35/00
[2004/15]
CPC:
G01N33/57446 (EP,US); A61P35/00 (EP); C12Q1/6897 (EP,US);
G01N2500/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/15]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:SCREENING-VERFAHREN ZUR IDENTIFIKATION VON KREBSTHERAPIE-RELEVANTEN VERBINDUNGEN[2004/15]
English:SCREENING METHOD[2004/15]
French:METHODE DE CRIBLAGE[2004/15]
Entry into regional phase26.01.2004National basic fee paid 
26.01.2004Designation fee(s) paid 
26.01.2004Examination fee paid 
Examination procedure24.01.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.01.2004Amendment by applicant (claims and/or description)
26.01.2004Examination requested  [2004/15]
01.02.2006Despatch of a communication from the examining division (Time limit: M08)
29.09.2006Reply to a communication from the examining division
31.07.2007Despatch of a communication from the examining division (Time limit: M02)
11.10.2007Application deemed to be withdrawn, date of legal effect  [2008/19]
30.11.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/19]
Fees paidRenewal fee
26.01.2004Renewal fee patent year 03
24.06.2005Renewal fee patent year 04
22.06.2006Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.200605   M06   Not yet paid
30.06.200706   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption23.05.2005Interruption of proceedings. Reason: legal prevention of applicant[2005/41]
01.02.2006Resumption of proceedings[2005/41]
Cited inInternational search[XY]  - ORDONEZ COSME ET AL, "Human carcinoembryonic antigen functions as a general inhibitor of anoikis.", CANCER RESEARCH, (20000701), vol. 60, no. 13, ISSN 0008-5472, pages 3419 - 3424, XP002214003 [X] 1-6,9,11-13,28-30,32 * figures 1-4 * [Y] 7,8,10,14,15
 [XY]  - SCREATON ROBERT A ET AL, "Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation.", JOURNAL OF CELL BIOLOGY, (1997), vol. 137, no. 4, ISSN 0021-9525, pages 939 - 952, XP002214004 [X] 28-30,32 * page 949 - page 951 * [Y] 13-15

DOI:   http://dx.doi.org/10.1083/jcb.137.4.939
 [XY]  - WAGENER C ET AL, "Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule 1.", EXPERIMENTAL CELL RESEARCH, (20001125), vol. 261, no. 1, ISSN 0014-4827, pages 19 - 24, XP002214005 [X] 1-8,11,12 * page 20, column 2 - page 21, column 1 * [Y] 14,15

DOI:   http://dx.doi.org/10.1006/excr.2000.5038
 [XY]  - SINGER BERNHARD B ET AL, "The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation.", CANCER RESEARCH, (20000301), vol. 60, no. 5, ISSN 0008-5472, pages 1236 - 1244, XP002214006 [X] 28-32 * column W * [Y] 14,15
 [X]  - CHEN CHARNG-JUI ET AL, "Role of interferon regulatory factor-1 in the induction of biliary glycoprotein (Cell CAM-1) by interferon-gamma.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1996), vol. 271, no. 45, ISSN 0021-9258, pages 28181 - 28188, XP002214007 [X] 1-8,11,12 * figures 1-3,6; table 2 *

DOI:   http://dx.doi.org/10.1074/jbc.271.45.28181
 [X]  - ERGUEN SUELEYMAN ET AL, "CEA-related cell adhesion molecule 1: A potent angiogenic factor and a major effector of vascular endothelial growth factor.", MOLECULAR CELL, (200002), vol. 5, no. 2, ISSN 1097-2765, pages 311 - 320, XP002214008 [X] 1-8,11,12 * figure 4 *

DOI:   http://dx.doi.org/10.1016/S1097-2765(00)80426-8
 [Y]  - SCHOELZEL STEFAN ET AL, "Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.", AMERICAN JOURNAL OF PATHOLOGY, (200002), vol. 156, no. 2, ISSN 0002-9440, pages 595 - 605, XP002214009 [Y] 1-15 * column W *
 [Y]  - RICHARDS C A ET AL, "Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy.", HUMAN GENE THERAPY. UNITED STATES JUL 1995, (199507), vol. 6, no. 7, ISSN 1043-0342, pages 881 - 893, XP000654733 [Y] 1-12 * column W *
Examination   - TI "The carcinoembryonic antigen (CEA) promotes metastatic growth, adhesion and affects the apoptotic rate of coloncancer cells" AU Wirth, Thomas et al. PUB Proceedings of the American Association for Cancer Research Annual Meeting IRN ISSN 0197-016x VOL 42 PG 790 CONF 92nd Annual Meeting
    - HUANG, JIE ET AL., "Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F", JOURNAL OF CELL SCIENCE, Great Britain, (1999), vol. 112, pages 4193 - 4205
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.